Meeting program

October 2, 2021

10:00 - 10:10 EET Opening remarks

10:10 - 11:40 EET Session 1: Multiple myeloma - Diagnosis & staging

Chairs: M Guenova (Bulgaria) & A Ivanaj (Albania)

  • State-of-the-Art
    E Terpos (Greece)
  • Prognostic significance of double and triple hit myeloma
    M Mitrovic (Serbia)
  • Berger's disease or MGRS (or both?)
    J Batinic (Croatia)
  • Multiple myeloma, diagnosis and approaches to treatment through the case report
    I Miketić (Montenegro)
  • Discussion
    All speakers

11:40 - 12:25 EET Break

12:25 - 13:55 EET Session 2: Multiple myeloma - Frontline therapy

Chairs: S Basic Kinda (Croatia) & H Bumbea (Romania)

  • State-of-the-Art
    M Beksaç (Turkey)
  • Treatment of an elderly transplant ineligible patient with newly diagnosed myeloma
    O Gokmen Sevindik (Turkey)
  • Treatment approach for young high risk myeloma patients - Implementing the new ESMO guidelines
    S Badelita (Romania)
  • Frontline treatment of patients with multiple myeloma in UMC Ljubljana over the 5-year period - Our experience
    N Kavčič (Slovenia)
  • Discussion
    All speakers

13:55 - 14:10 EET Break

14:10 - 15:40 EET Session 3: Multiple myeloma in the Relapsed/Refractory Patient

Chairs: J Bila (Serbia) & S Zver (Slovenia)

  • State-of-the-Art
    P Sonneveld (The Netherlands)
  • Impact of new ESMO guidelines on the treatment of RRMM patients in Bulgaria
    V Goranova-Marinova (Bulgaria)
  • A case of Multiple Myeloma patient assiciated with testicular Non Hodgkin Lymphoma
    A Cili (Albania)
  • Management of a patient presented with extramedullary relapse after ASCT followed by lenilidomide maintenance
    E Katodritou (Greece)
  • Discussion
    All speakers

15:40 - 16:00 EET Closing remarks - Future in medicine through scientific collaboration